Litcius/Paper detail

CEBPG promotes esophageal squamous cell carcinoma progression by enhancing PI3K-AKT signaling.

Yongsheng Huang, Lehang Lin, Zhuojian Shen, Yu Li, Haotian Cao, Li Peng, Yuntan Qiu, Cheng Xu, Meng Meng, Daning Lu, Dong Yin

2020PubMed28 citationsOpen Access PDF

Abstract

, etc. These findings provide new insights into CEBPs dysregulation in ESCC and elucidate a crucial role for CEBPG in the progression of ESCC, highlighting its potential therapeutic value for ESCC treatment.

Topics & Concepts

Cancer researchTranscription factorProtein kinase BPI3K/AKT/mTOR pathwayEnhancerBiologyCcaat-enhancer-binding proteinsDownregulation and upregulationCyclin D1Signal transductionCEBPACellGeneCell biologyCell cycleDNA-binding proteinGeneticsRNA modifications and cancerEpigenetics and DNA MethylationFerroptosis and cancer prognosis
CEBPG promotes esophageal squamous cell carcinoma progression by enhancing PI3K-AKT signaling. | Litcius